Jennison Associates’s LeMaitre Vascular LMAT Stock Holding History

Jennison Associates’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$915K	Buy	+9,533	New	+$977K	﹤0.01%	511

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates's LMAT Position: Q2 2026 in Review

Jennison Associates opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 9,533 shares worth $915K. The stake represents ﹤0.01% of the portfolio and ranks #511 among its holdings.

326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Jennison Associates held 9,533 shares of LeMaitre Vascular worth $915K as of Q2 2026.
LeMaitre Vascular was a new Jennison Associates position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #511 holding.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.